Sabbatini PJ - Search Results

1

Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer.

Manning-Geist BL, Gordhandas SB, Giri DD, Iasonos A, Zhou Q, Girshman J, O'Cearbhaill RE, Zamarin D, Lichtman SM, Sabbatini PJ, Tew WP, Li K, McDonnell AS, Aviki EM, Chi DS, Aghajanian CA, Grisham RN. Manning-Geist BL, et al. Among authors: sabbatini pj. Gynecol Oncol. 2022 Jan;164(1):12-17. doi: 10.1016/j.ygyno.2021.10.087. Epub 2021 Nov 8. Gynecol Oncol. 2022. PMID: 34763937 Free PMC article. Clinical Trial.

2

Salvage therapy for ovarian cancer.

Sabbatini P, Spriggs D. Sabbatini P, et al. Oncology (Williston Park). 1998 Jun;12(6):833-43; discussion 844-6, 848, 851. Oncology (Williston Park). 1998. PMID: 9644684 Free article. Review.

3

Chemotherapy in gynecologic cancer.

Sabbatini P, Aghajanian C, Spriggs D. Sabbatini P, et al. Curr Opin Oncol. 1998 Sep;10(5):429-33. doi: 10.1097/00001622-199809000-00010. Curr Opin Oncol. 1998. PMID: 9800113 Review.

4

Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer.

Husain A, Sabbatini P, Spriggs D, Fennelly D, Aghajanian C, Barakat R, Curtin J, Venkatraman E, Hoskins W, Markman M. Husain A, et al. Gynecol Oncol. 1999 Apr;73(1):96-101. doi: 10.1006/gyno.1998.5317. Gynecol Oncol. 1999. PMID: 10094887 Clinical Trial.

5

Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial.

Sabbatini PJ, Kudryashov V, Ragupathi G, Danishefsky SJ, Livingston PO, Bornmann W, Spassova M, Zatorski A, Spriggs D, Aghajanian C, Soignet S, Peyton M, O'Flaherty C, Curtin J, Lloyd KO. Sabbatini PJ, et al. Int J Cancer. 2000 Jul 1;87(1):79-85. Int J Cancer. 2000. PMID: 10861456 Free article. Clinical Trial.

6

Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look.

Makhija S, Sabbatini P, Aghajanian C, Venkatraman E, Spriggs DR, Barakat R. Makhija S, et al. Gynecol Oncol. 2000 Oct;79(1):28-32. doi: 10.1006/gyno.2000.5890. Gynecol Oncol. 2000. PMID: 11006026 Clinical Trial.

7

Complications associated with intraperitoneal chemotherapy catheters.

Makhija S, Leitao M, Sabbatini P, Bellin N, Almadrones L, Leon L, Spriggs DR, Barakat R. Makhija S, et al. Gynecol Oncol. 2001 Apr;81(1):77-81. doi: 10.1006/gyno.2000.6108. Gynecol Oncol. 2001. PMID: 11277654

8

Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.

Hensley ML, Lebeau D, Leon LF, Venkatraman E, Waltzman R, Sabbatini P, Almadrones L, Chi D, Spriggs D. Hensley ML, et al. Gynecol Oncol. 2001 Jun;81(3):485-9. doi: 10.1006/gyno.2001.6185. Gynecol Oncol. 2001. PMID: 11371143

9

The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patients.

Hensley ML, Hoppe B, Leon L, Sabbatini P, Aghajanian C, Chi D, Spriggs DR. Hensley ML, et al. Gynecol Oncol. 2001 Sep;82(3):464-9. doi: 10.1006/gyno.2001.6299. Gynecol Oncol. 2001. PMID: 11520141

10

Endometrial stromal sarcoma: objective response to letrozole.

Maluf FC, Sabbatini P, Schwartz L, Xia J, Aghajanian C. Maluf FC, et al. Gynecol Oncol. 2001 Aug;82(2):384-8. doi: 10.1006/gyno.2001.6238. Gynecol Oncol. 2001. PMID: 11531300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

145 results

Search Page